Nordea Investment Management AB decreased its position in shares of uniQure (NASDAQ:QURE – Get Rating) by 1.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 272,781 shares of the biotechnology company’s stock after selling 4,150 shares during the period. Nordea Investment […]
uniQure (NASDAQ:QURE – Get Rating) CEO Matthew C. Kapusta sold 10,195 shares of the stock in a transaction on Monday, February 28th. The shares were sold at an average price of $16.70, for a total value of $170,256.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this […]
Hudson Bay Capital Management LP raised its position in shares of uniQure (NASDAQ:QURE – Get Rating) by 12.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 260,000 shares of the biotechnology company’s stock after acquiring an additional 28,900 shares during the quarter. Hudson Bay […]
Shares of uniQure (NASDAQ:QURE – Get Rating) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price target among analysts […]